Literature DB >> 25856213

Subclinical Hypothyroidism and the Risk of Stroke Events and Fatal Stroke: An Individual Participant Data Analysis.

Layal Chaker1, Christine Baumgartner1, Wendy P J den Elzen1, M Arfan Ikram1, Manuel R Blum1, Tinh-Hai Collet1, Stephan J L Bakker1, Abbas Dehghan1, Christiane Drechsler1, Robert N Luben1, Albert Hofman1, Marileen L P Portegies1, Marco Medici1, Giorgio Iervasi1, David J Stott1, Ian Ford1, Alexandra Bremner1, Christoph Wanner1, Luigi Ferrucci1, Anne B Newman1, Robin P Dullaart1, José A Sgarbi1, Graziano Ceresini1, Rui M B Maciel1, Rudi G Westendorp1, J Wouter Jukema1, Misa Imaizumi1, Jayne A Franklyn1, Douglas C Bauer1, John P Walsh1, Salman Razvi1, Kay-Tee Khaw1, Anne R Cappola1, Henry Völzke1, Oscar H Franco1, Jacobijn Gussekloo1, Nicolas Rodondi1, Robin P Peeters1.   

Abstract

OBJECTIVE: The objective was to determine the risk of stroke associated with subclinical hypothyroidism. DATA SOURCES AND STUDY SELECTION: Published prospective cohort studies were identified through a systematic search through November 2013 without restrictions in several databases. Unpublished studies were identified through the Thyroid Studies Collaboration. We collected individual participant data on thyroid function and stroke outcome. Euthyroidism was defined as TSH levels of 0.45-4.49 mIU/L, and subclinical hypothyroidism was defined as TSH levels of 4.5-19.9 mIU/L with normal T4 levels. DATA EXTRACTION AND SYNTHESIS: We collected individual participant data on 47 573 adults (3451 subclinical hypothyroidism) from 17 cohorts and followed up from 1972-2014 (489 192 person-years). Age- and sex-adjusted pooled hazard ratios (HRs) for participants with subclinical hypothyroidism compared to euthyroidism were 1.05 (95% confidence interval [CI], 0.91-1.21) for stroke events (combined fatal and nonfatal stroke) and 1.07 (95% CI, 0.80-1.42) for fatal stroke. Stratified by age, the HR for stroke events was 3.32 (95% CI, 1.25-8.80) for individuals aged 18-49 years. There was an increased risk of fatal stroke in the age groups 18-49 and 50-64 years, with a HR of 4.22 (95% CI, 1.08-16.55) and 2.86 (95% CI, 1.31-6.26), respectively (p trend 0.04). We found no increased risk for those 65-79 years old (HR, 1.00; 95% CI, 0.86-1.18) or ≥ 80 years old (HR, 1.31; 95% CI, 0.79-2.18). There was a pattern of increased risk of fatal stroke with higher TSH concentrations.
CONCLUSIONS: Although no overall effect of subclinical hypothyroidism on stroke could be demonstrated, an increased risk in subjects younger than 65 years and those with higher TSH concentrations was observed.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25856213      PMCID: PMC4454799          DOI: 10.1210/jc.2015-1438

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  68 in total

Review 1.  Thyroid hormone and the cardiovascular system.

Authors:  I Klein; K Ojamaa
Journal:  N Engl J Med       Date:  2001-02-15       Impact factor: 91.245

2.  Quantifying heterogeneity in a meta-analysis.

Authors:  Julian P T Higgins; Simon G Thompson
Journal:  Stat Med       Date:  2002-06-15       Impact factor: 2.373

3.  Subclinical thyroid dysfunction as a risk factor for cardiovascular disease.

Authors:  John P Walsh; Alexandra P Bremner; Max K Bulsara; Peter O'Leary; Peter J Leedman; Peter Feddema; Valdo Michelangeli
Journal:  Arch Intern Med       Date:  2005-11-28

4.  Cohort profile: the study of health in Pomerania.

Authors:  Henry Völzke; Dietrich Alte; Carsten Oliver Schmidt; Dörte Radke; Roberto Lorbeer; Nele Friedrich; Nicole Aumann; Katharina Lau; Michael Piontek; Gabriele Born; Christoph Havemann; Till Ittermann; Sabine Schipf; Robin Haring; Sebastian E Baumeister; Henri Wallaschofski; Matthias Nauck; Stephanie Frick; Andreas Arnold; Michael Jünger; Julia Mayerle; Matthias Kraft; Markus M Lerch; Marcus Dörr; Thorsten Reffelmann; Klaus Empen; Stephan B Felix; Anne Obst; Beate Koch; Sven Gläser; Ralf Ewert; Ingo Fietze; Thomas Penzel; Martina Dören; Wolfgang Rathmann; Johannes Haerting; Mario Hannemann; Jürgen Röpcke; Ulf Schminke; Clemens Jürgens; Frank Tost; Rainer Rettig; Jan A Kors; Saskia Ungerer; Katrin Hegenscheid; Jens-Peter Kühn; Julia Kühn; Norbert Hosten; Ralf Puls; Jörg Henke; Oliver Gloger; Alexander Teumer; Georg Homuth; Uwe Völker; Christian Schwahn; Birte Holtfreter; Ines Polzer; Thomas Kohlmann; Hans J Grabe; Dieter Rosskopf; Heyo K Kroemer; Thomas Kocher; Reiner Biffar; Ulrich John; Wolfgang Hoffmann
Journal:  Int J Epidemiol       Date:  2010-02-18       Impact factor: 7.196

5.  Design and baseline characteristics of the osteoporotic fractures in men (MrOS) study--a large observational study of the determinants of fracture in older men.

Authors:  Eric Orwoll; Janet Babich Blank; Elizabeth Barrett-Connor; Jane Cauley; Steven Cummings; Kristine Ensrud; Cora Lewis; Peggy M Cawthon; Robert Marcus; Lynn M Marshall; Joan McGowan; Kathy Phipps; Sherry Sherman; Marcia L Stefanick; Katie Stone
Journal:  Contemp Clin Trials       Date:  2005-10       Impact factor: 2.226

6.  A solution to the problem of monotone likelihood in Cox regression.

Authors:  G Heinze; M Schemper
Journal:  Biometrics       Date:  2001-03       Impact factor: 2.571

7.  Thyroid function, cardiovascular events, and mortality in diabetic hemodialysis patients.

Authors:  Christiane Drechsler; Andreas Schneider; Lena Gutjahr-Lengsfeld; Matthias Kroiss; Juan Jesús Carrero; Vera Krane; Bruno Allolio; Christoph Wanner; Martin Fassnacht
Journal:  Am J Kidney Dis       Date:  2013-12-04       Impact factor: 8.860

8.  The incidence of ischemic heart disease and mortality in people with subclinical hypothyroidism: reanalysis of the Whickham Survey cohort.

Authors:  Salman Razvi; Jola U Weaver; Mark P Vanderpump; Simon H S Pearce
Journal:  J Clin Endocrinol Metab       Date:  2010-02-11       Impact factor: 5.958

9.  Meta-analysis: subclinical thyroid dysfunction and the risk for coronary heart disease and mortality.

Authors:  Nicolas Ochs; Reto Auer; Douglas C Bauer; David Nanchen; Jacobijn Gussekloo; Jacques Cornuz; Nicolas Rodondi
Journal:  Ann Intern Med       Date:  2008-05-19       Impact factor: 25.391

Review 10.  Cardiovascular effects of mild hypothyroidism.

Authors:  Bernadette Biondi
Journal:  Thyroid       Date:  2007-07       Impact factor: 6.568

View more
  55 in total

1.  The Rotterdam Study: 2016 objectives and design update.

Authors:  Albert Hofman; Guy G O Brusselle; Sarwa Darwish Murad; Cornelia M van Duijn; Oscar H Franco; André Goedegebure; M Arfan Ikram; Caroline C W Klaver; Tamar E C Nijsten; Robin P Peeters; Bruno H Ch Stricker; Henning W Tiemeier; André G Uitterlinden; Meike W Vernooij
Journal:  Eur J Epidemiol       Date:  2015-09-19       Impact factor: 8.082

2.  Levothyroxine prescribing and laboratory test use after a minor change in reference range for thyroid-stimulating hormone.

Authors:  Christopher Symonds; Gregory Kline; Inelda Gjata; Marianne Sarah Rose; Maggie Guo; Lara Cooke; Christopher Naugler
Journal:  CMAJ       Date:  2020-05-04       Impact factor: 8.262

3.  Major adverse cardiovascular and cerebral events in hypothyroid patients undergoing percutaneous coronary intervention.

Authors:  Giuseppe Pasqualetti; Valeria Calsolaro; Fabio Monzani
Journal:  J Thorac Dis       Date:  2016-06       Impact factor: 2.895

Review 4.  Subclinical hypothyroidism in childhood - current knowledge and open issues.

Authors:  Mariacarolina Salerno; Donatella Capalbo; Manuela Cerbone; Filippo De Luca
Journal:  Nat Rev Endocrinol       Date:  2016-07-01       Impact factor: 43.330

5.  Effect of metformin on thyroid function tests in patients with subclinical hypothyroidism: an open-label randomised controlled trial.

Authors:  R Palui; J Sahoo; S Kamalanathan; S S Kar; K Sridharan; H Durgia; H Raj; M Patil
Journal:  J Endocrinol Invest       Date:  2019-05-24       Impact factor: 4.256

6.  Hyperhomocysteinemia in acute iatrogenic hypothyroidism: the relevance of thyroid autoimmunity.

Authors:  F Cicone; M G Santaguida; G My; G Mancuso; A Papa; R Persechino; C Virili; N Brusca; A Tofani; F Scopinaro; M Centanni
Journal:  J Endocrinol Invest       Date:  2017-12-29       Impact factor: 4.256

7.  The Rotterdam Study: 2018 update on objectives, design and main results.

Authors:  M Arfan Ikram; Guy G O Brusselle; Sarwa Darwish Murad; Cornelia M van Duijn; Oscar H Franco; André Goedegebure; Caroline C W Klaver; Tamar E C Nijsten; Robin P Peeters; Bruno H Stricker; Henning Tiemeier; André G Uitterlinden; Meike W Vernooij; Albert Hofman
Journal:  Eur J Epidemiol       Date:  2017-10-24       Impact factor: 8.082

8.  Nocturnal Non-Dipping: An Overlooked Clinical Manifestation of Subclinical Hypothyroidism Linking to Increased Cardiovascular Risk.

Authors:  Hung-Ju Lin; Tzung-Dau Wang
Journal:  Acta Cardiol Sin       Date:  2017-09       Impact factor: 2.672

9.  Thyroid stimulating hormone elevation as a predictor of long-term mortality in patients with acute myocardial infarction.

Authors:  Suk Min Seo; Yoon-Seok Koh; Hun-Jun Park; Dong Bin Kim; Sung Ho Her; Jong Min Lee; Chul Soo Park; Pum-Joon Kim; Hee Yeol Kim; Ki Dong Yoo; Doo Soo Jeon; Young Keun Ahn; Myung Ho Jeong; Wook Sung Chung; Ki-Bae Seung
Journal:  Clin Cardiol       Date:  2018-10-16       Impact factor: 2.882

10.  Thyroid Function Within the Reference Range and the Risk of Stroke: An Individual Participant Data Analysis.

Authors:  Layal Chaker; Christine Baumgartner; Wendy P J den Elzen; Tinh-Hai Collet; M Arfan Ikram; Manuel R Blum; Abbas Dehghan; Christiane Drechsler; Robert N Luben; Marileen L P Portegies; Giorgio Iervasi; Marco Medici; David J Stott; Robin P Dullaart; Ian Ford; Alexandra Bremner; Anne B Newman; Christoph Wanner; José A Sgarbi; Marcus Dörr; W T Longstreth; Bruce M Psaty; Luigi Ferrucci; Rui M B Maciel; Rudi G Westendorp; J Wouter Jukema; Graziano Ceresini; Misa Imaizumi; Albert Hofman; Stephan J L Bakker; Jayne A Franklyn; Kay-Tee Khaw; Douglas C Bauer; John P Walsh; Salman Razvi; Jacobijn Gussekloo; Henry Völzke; Oscar H Franco; Anne R Cappola; Nicolas Rodondi; Robin P Peeters
Journal:  J Clin Endocrinol Metab       Date:  2016-09-07       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.